Elucid Bio Archives - NeuroNews International

Study shows novel AI technology is better predictor of stroke than...

2 July 2020

Boston-based medical technology company Elucid Bio, maker of the Food and Drug Administration (FDA)-cleared and CE-marked vascuCAP software, announced Wednesday, July 1, that its...

Write to us
Editor: Jamie Bell [email protected]
Advertising: Michael Broughton [email protected]

United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: [email protected]

United States:

BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: [email protected]

Terms and Conditions | Privacy Policy

Tag: Elucid Bio

Study shows novel AI technology is better predictor of stroke than...